|
|

|
|
Title:
Hypoglycemic 5-substituted oxazolidine-2,4-diones
Abstract:
Hypoglycemic 5-phenyl and 5-naphthyl oxazolidine-2,4-diones and the pharmaceutically-acceptable salts thereof; certain 3-acylated derivatives thereof; a method of treating hyperglycemic animals therewith; and intermediates useful in the preparation of said compounds.
Do you think this is a good invention? Vote now:
Votes so far: For:(0) Against:(0) Other info:
Inventors:
Schnur, Rodney C. (Noank, CT)
Application Number:
06/353467
Filing Date: 1982-03-01 Publication_date: 1983-10-04 Assignee:
Pfizer (US)
Primary Class(es):
514/374
548/226, 514/376, 514/377
Other Classes:
C07C45/51; C07C45/00; C07D263/32; A61K31/42
US Patent Ref:
| 3699229 | October, 1972 | Plotnikoff | 424/272 | |
Other Refs:
Other References:
Clark-Lewis, Chem. Rev. 58, pp. 63-99, (1958).
Brink and Freeman, J. Neuro. Chem. 19 (7), pp. 1783-1788 (1972).
Primary Examiner:
Daus, Donald G.
Assistant Examiner:
Gibson, Sharon A.
Attorney:
Knuth, Charles J.
Frost, Albert E.
Blackwood, Robert K.
Parent Case Data:
CROSS REFERENCE TO RELATED
|
|

|